Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Allovir Inc
(NQ:
ALVR
)
0.5499
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Allovir Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet
June 22, 2023
U.S. stocks traded mostly higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Thursday. The Dow traded down 0.03% to 33,942.78 while the NASDAQ rose 0.75% to...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 22, 2023
Via
Benzinga
Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike Higher
June 22, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 70 points on Thursday. The Dow traded down 0.11% to 33,912.98 while the NASDAQ rose 0.54% to 13,574.90. The S&P...
Via
Benzinga
Tesla (TSLA) Stock Slides After Second Downgrade This Week
June 22, 2023
Tesla (TSLA) stock is on the move Thursday after the company got hit with its second downgrade this week, despite increased price targets.
Via
InvestorPlace
US Stocks Lower Following Initial Jobless Claims Report
June 22, 2023
U.S. stocks traded lower this morning, with Nasdaq Composite dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.16% to 33,895.80 while the NASDAQ fell...
Via
Benzinga
Why AlloVir Stock Is Diving Thursday
June 22, 2023
AlloVir Inc (NASDAQ: ALVR) shares are trading lower after the company priced a public offering of common stock.
Via
Benzinga
Why Is AlloVir (ALVR) Stock Down 23% Today?
June 22, 2023
AlloVir (ALVR) stock is falling hard on Thursday after the company announced the pricing of a $75 million public share offering.
Via
InvestorPlace
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 22, 2023
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...
Via
Benzinga
Why Is Gulfport Energy (GPOR) Stock Down 8% Today?
June 22, 2023
Gulfport Energy (GPOR) stock is falling on Thursday after the company revealed details of a public share offering from certain investors.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 22, 2023
Via
Benzinga
Why AlloVir Stock Is Tumbling After Hours
June 21, 2023
AlloVir Inc (NASDAQ: ALVR) shares are trading lower in Wednesday's after-hours session after the company proposed a public offering.
Via
Benzinga
AlloVir: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
Why Root Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
June 22, 2023
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 100.8% to $2.65 in pre-market trading after dropping 43% on Wednesday.
Via
Benzinga
AlloVir, DigitalOcean And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 22, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. AlloVir, Inc. (NASDAQ: ALVR) shares dipped 24.1% to $3.74 in pre-market...
Via
Benzinga
AlloVir Announces Pricing of Public Offering of Common Stock
June 21, 2023
From
AlloVir, Inc.
Via
Business Wire
AlloVir Announces Proposed Public Offering of Common Stock
June 21, 2023
From
AlloVir, Inc.
Via
Business Wire
Why Shares of AlloVir Jumped This Week
June 09, 2023
The company's lead therapy fared well in preventing infections for kidney transplant patients.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 06, 2023
Via
Benzinga
AlloVir Presents Positive Final Results From A Phase 2 Randomized, Placebo-Controlled Trial Evaluating Posoleucel Treatment of BK Infection in Kidney Transplant Recipients at the American Transplant Congress (ATC 2023)
June 05, 2023
From
AlloVir, Inc.
Via
Business Wire
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 06, 2023
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.
Via
Benzinga
AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer
May 16, 2023
From
AlloVir
Via
Business Wire
AlloVir Reports First Quarter 2023 Financial Results
May 04, 2023
From
AlloVir
Via
Business Wire
AlloVir to Present at the BofA Securities 2023 Health Care Conference
May 01, 2023
From
AlloVir, Inc.
Via
Business Wire
AlloVir's Posoleucel Achieves Non-Relapse Mortality Of 0% In Transplant Patients For Viral Infections
April 26, 2023
AlloVir Inc (NASDAQ: ALVR) announced the presentation of long-term, follow-up data from the Phase 2 study of posoleucel to prevent infections from six viruses in allogeneic hematopoietic cell...
Via
Benzinga
AlloVir Announces Positive Results Including Long-Term Mortality Data in Phase 2 Posoleucel Multi-Virus Prevention Study in Oral Presentation at EBMT 2023
April 26, 2023
From
AlloVir, Inc.
Via
Business Wire
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday
April 13, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 09, 2023
Via
Benzinga
AlloVir Appoints Derek Adams, Ph.D., to Board of Directors
February 23, 2023
From
AlloVir
Via
Business Wire
AlloVir Announces Final Results From Posoleucel Study In Kidney Transplant Recipients With BK Viremia, Shares Fall
February 15, 2023
Via
Benzinga
AlloVir Reports Full-Year 2022 Financial Results and 2023 Outlook
February 15, 2023
From
AlloVir, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.